Antibiotice

tlina Isuflet

CURRENT REPORT

Accordi ng to:

  • Law 297/2004 amended and completed by the provisions of L10/2015 and GEO 90/2014 and the regulations of the Romanian National Securities Commission (CNVM) issued in view of its application,

  • The regulations of the National Securities Commission no. 1/2006 on the issuers and the securities-related operations, amended by introducing the provisions of the ASF Regulation no. 13/2014,

  • The Regulation of CNVM no. 6/2009 on the exercise of certain rights of shareholders within the general meetings of trading companies,

  • Disposal of measures no. 26/20.12.2012,

  • GEO no. 109/2011 on the corporate governance of public enterprises,

  • Law no. 31/1990 republished, with all subsequent amendments,

  • Articles of Association.

Report date: 14.08.2017

Name of issuing company: Antibiotice SA

Headquarters: lai, 1 Valea Lupului St., postal code 707410, http://www.antibiotice.ro E-mail: relatiicuinvestitorii@antibiotice.ro

Telephone/fax no.: 0232 209 000 I 0372 065 633

Unique registration code in the Trade Register Office: R01973096 Order number in the Trade Register: J22/285/1991

Subscribed and paid-up capital: 67,133,804 LEI

The regulated market on which the issued securities are traded: Bucharest Stock Exchange Number of shares: 671,338,040

Number of votes: 671,338,040

Main characteristics of the securities issued by the company: nominative shares, nominal value:

0.10 LEI

Significant event to report:

The report of the Financial Auditor BDO AUDIT SRL on the provisions of the GEO 29/2017 on the distribution of the company·s dividends starting with 31.12.2016 was submitted in the meeting of the Management Board held on 14.08.2017.The conclusion of this report is that the provisions of GEO 29/2017 have no impact both on the reserves and on the reported result presented in the Financial Statements of the company at 31.12.2016, in other words the company can not allocate additional dividends to the analyzed financial situation.

It is noted that dividends approved by the Ordinary General Meeting of the Shareholders on

06.04. 2017 are correctly calculated and allocated, other additional amounts as dividends are not appropriate, therefore another OGMS on this subject is devoid of purpose.

VicePresident of Management Board ec. loan NANI

Valea Lupufui nr. 1 lai 707410.Rou,ania T +40 232 209 000

T +40 372 065000

f • 40 232 209 633

www.antibioticP.ro

122/ 285/1991

CUI RO 1973096

IOAN,RO 04 OACX 0000 00301067 8000

Antibiotice SA published this content on 14 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 September 2017 16:42:03 UTC.

Original documenthttp://www.antibiotice.ro/wp-content/uploads/2017/08/Raport-curent-eng.pdf

Public permalinkhttp://www.publicnow.com/view/A6F8584BE3904A74FE68FE4BCC63CACF35EF1D64